Health Trials

About this trial

Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.

Eligibility criteria

Qualifiers

Migraine patients according to ICHD-3 criteria

Healthy controls paired to patient age and sex, without headache and without first degree family history of headache.

Disqualifiers

Presence of any major medical or neurological illness.

Presence of any salivary gland malfunction.

Abuse or dependence to tobacco, alcohol or any drug in the previous 12 months before the enrollment.

Active migraine preventive treatment.

Trial design

Treatments tested in this trial

  • Saliva test

Treatment groups

440 Participants
are divided into 2 treatment groups

Locations

1
Vall d'Hebron University Hospital08035, BarcelonaBarcelona, Spain

Sponsors and collaborators

Hospital Universitari Vall d'Hebron Research Institute

Lead sponsor

Source ClinicalTrials.gov